Agena Bioscience® in the News

Agena Bioscience Opens Office in Shanghai, China

1 September 2015

SAN DIEGO, Calif., Sep. 1, 2015 — Agena Bioscience today announced the establishment of a subsidiary in Shanghai, a commercial and financial hub from which many biotech and life science firms serve the growing number of genomic testing laboratories in mainland China.

“The Chinese market represents a significant portion of Agena Bioscience’s global sales with almost sixty MassARRAY® Systems installed to date. Direct presence within China will allow us to expand our reach and foster a high degree of engagement with our local customers in that region,” said Pete Dansky, CEO.

Bob Wang has joined Agena Bioscience as its Vice President and General Manager, Greater China. Bob most recently was Marketing Director for QIAGEN, responsible for leading the development of its molecular diagnostics and life science commercial strategies. Prior to this, Bob held senior positions encompassing Business Development, Marketing, Sales, and Regulatory Affairs at Hologic, Life Technologies, Applied Biosystems, and the Chinese Human Genome Center.

“We are delighted to have Bob leading our Greater China organization. His experience in both clinical diagnostics and life science research will help drive Agena Bioscience’s strategy and commercial execution in China,” said Dansky.

The MassARRAY System by Agena BioscienceTM provides a mid-plex technology for targeted profiling of 10’s to 100s of genetic markers. The system offers a practical solution for today’s clinical and translational research labs with improvements in cost, throughput, reimbursement, and ease of use over alternative methods. The MassARRAY System is used in 37 countries worldwide with an installed base of 350+ systems. 

About Agena Bioscience

Agena Bioscience develops, manufactures, and supplies genetic analysis systems and reagents, including the MassARRAY System. The system is a highly sensitive, cost-effective, mass spectrometry-based platform for high-throughput genetic analysis, and is used globally in diverse fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research.  The MassARRAY System is intended for research use only, and not intended for use in diagnostic procedures.